Abstract| Volume 275, e171, August 2018

Adequate glycemic control prevents cholesterol efflux impairment and lipid accumulation in macrophages induced by advanced glycated albumin

      Aim: Advanced glycation end products (AGE) predict the development of atherosclerosis. AGE-albumin from poorly controlled diabetes mellitus (DM) patients impairs macrophage cholesterol efflux by reducing ABCA-1. We analyzed if an adequate glycemic control (aGC) is able to prevent alterations in cholesterol efflux elicited by DM-albumin.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect